{"id":410244,"date":"2021-01-07T08:03:11","date_gmt":"2021-01-07T13:03:11","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=410244"},"modified":"2021-01-07T08:03:11","modified_gmt":"2021-01-07T13:03:11","slug":"azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/","title":{"rendered":"AzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference"},"content":{"rendered":"
\n

DELRAY BEACH, Fla., Jan. 07, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (\u201cAzurRx\u201d or the \u201cCompany\u201d), a company specializing in the development of targeted, non-systemic\u00a0therapies for\u00a0gastrointestinal (GI) diseases, today announced that the Company will be participating in this year\u2019s Biotech Showcase Digital 2021 conference.<\/p>\n

James Sapirstein, President & CEO of AzurRx BioPharma, and the Company\u2019s senior management team will be participating in virtual one-on-one meetings with registered investors and pharmaceutical companies. The AzurRx team will be available to provide an overview of the Company\u2019s business and clinical development programs and discuss anticipated 2021 milestones.<\/p>\n

Details of the event are as follows:<\/p>\n\n\n\n\n
\n Event:<\/strong>\n <\/td>\n\n \u00a0<\/strong>\n <\/td>\n\n Biotech Showcase Digital<\/strong>\n <\/td>\n<\/tr>\n
\n Date:\u00a0<\/strong>\n <\/td>\n\n \u00a0<\/strong>\n <\/td>\nJanuary 11-15, 2021<\/td>\n<\/tr>\n
\n Registration:<\/strong>\n <\/td>\n\n \u00a0<\/strong>\n <\/td>\n\n
\n https:\/\/informaconnect.com\/biotech-showcase\/registration-options\/<\/strong>
\n <\/a>\n <\/td>\n<\/tr>\n<\/table>\n

\n About AzurRx BioPharma, Inc.<\/strong>
\n
AzurRx BioPharma, Inc. (NASDAQ: AZRX) is a clinical stage biopharmaceutical company\u00a0specializing\u00a0in the development of targeted, non-systemic therapies for\u00a0gastrointestinal (GI) diseases. The Company has a pipeline of three gut-restricted GI assets. The lead therapeutic candidate is\u00a0MS1819<\/strong>, a recombinant lipase for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis and chronic pancreatitis,\u00a0currently in two Phase 2 clinical trials.\u00a0AzurRx is launching two clinical programs using proprietary formulations of niclosamide, a pro-inflammatory pathway inhibitor;\u00a0FW-420<\/strong>, for grade 1 Immune Checkpoint Inhibitor Colitis and diarrhea in oncology patients and\u00a0FW-1022<\/strong>, for COVID-19 gastrointestinal infections. The Company is headquartered in Delray Beach, Florida with clinical operations in Hayward, California. Additional information on the Company can be found at\u00a0www.azurrx.com<\/a>.<\/p>\n

\n Forward-Looking Statements<\/strong>
\n
\n This press release may contain certain statements relating to future results which are forward-looking statements. These statements are not historical facts, but instead represent only the Company\u2019s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company\u2019s control. It is possible that the Company\u2019s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements, including whether results obtained in preclinical and nonclinical studies and clinical trials will be indicative of results obtained in future clinical trials; whether preliminary or interim results from a clinical trial such as the interim results presented will be indicative of the final results of the trial. Additional information concerning the Company and its business, including a discussion of factors that could materially affect the Company\u2019s financial results, including those related to the clinical development of its clinical assets, the results of its clinical trials, and the impact of the coronavirus (COVID-19) pandemic on the Company\u2019s operations and current and planned clinical trials, including, but not limited to delays in clinical trial recruitment and participation are contained in the Company\u2019s Annual Report on Form 10-K for the year ended December 31, 2019 under the heading\u00a0\u201cRisk Factors,\u201d\u00a0as well as the Company\u2019s subsequent filings with the Securities and Exchange Commission. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.<\/em>\n <\/p>\n

\n
\n For more information:<\/em>
\n <\/strong>\n <\/p>\n

AzurRx BioPharma, Inc.
1615 South Congress Avenue
Suite 103
Delray Beach, Florida 33445
Phone: (646) 699-7855
info@azurrx.com<\/a><\/p>\n

\n Investor Relations contact:<\/strong>\n <\/p>\n

LifeSci Advisors, LLC.\u00a0
Hans Vitzthum, Managing Director\u00a0
1 International Place, Suite 1480\u00a0
Boston, MA 02110\u00a0
Phone: (617) 430-7578\u00a0
hans@lifesciadvisors.com<\/a><\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

DELRAY BEACH, Fla., Jan. 07, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (\u201cAzurRx\u201d or the \u201cCompany\u201d), a company specializing in the development of targeted, non-systemic\u00a0therapies for\u00a0gastrointestinal (GI) diseases, today announced that the Company will be participating in this year\u2019s Biotech Showcase Digital 2021 conference. James Sapirstein, President & CEO of AzurRx BioPharma, and the Company\u2019s senior management team will be participating in virtual one-on-one meetings with registered investors and pharmaceutical companies. The AzurRx team will be available to provide an overview of the Company\u2019s business and clinical development programs and discuss anticipated 2021 milestones. Details of the event are as follows: Event: \u00a0 Biotech Showcase Digital Date:\u00a0 \u00a0 January 11-15, 2021 Registration: \u00a0 https:\/\/informaconnect.com\/biotech-showcase\/registration-options\/ About AzurRx BioPharma, Inc. … <\/p>\n

Continue reading “AzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-410244","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DELRAY BEACH, Fla., Jan. 07, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (\u201cAzurRx\u201d or the \u201cCompany\u201d), a company specializing in the development of targeted, non-systemic\u00a0therapies for\u00a0gastrointestinal (GI) diseases, today announced that the Company will be participating in this year\u2019s Biotech Showcase Digital 2021 conference. James Sapirstein, President & CEO of AzurRx BioPharma, and the Company\u2019s senior management team will be participating in virtual one-on-one meetings with registered investors and pharmaceutical companies. The AzurRx team will be available to provide an overview of the Company\u2019s business and clinical development programs and discuss anticipated 2021 milestones. Details of the event are as follows: Event: \u00a0 Biotech Showcase Digital Date:\u00a0 \u00a0 January 11-15, 2021 Registration: \u00a0 https:\/\/informaconnect.com\/biotech-showcase\/registration-options\/ About AzurRx BioPharma, Inc. … Continue reading "AzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-07T13:03:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTg5OSMzOTA4MTc5IzIwODIyMDc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference\",\"datePublished\":\"2021-01-07T13:03:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\\\/\"},\"wordCount\":569,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTg5OSMzOTA4MTc5IzIwODIyMDc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\\\/\",\"name\":\"AzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTg5OSMzOTA4MTc5IzIwODIyMDc=\",\"datePublished\":\"2021-01-07T13:03:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTg5OSMzOTA4MTc5IzIwODIyMDc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTg5OSMzOTA4MTc5IzIwODIyMDc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/","og_locale":"en_US","og_type":"article","og_title":"AzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference - Market Newsdesk","og_description":"DELRAY BEACH, Fla., Jan. 07, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (\u201cAzurRx\u201d or the \u201cCompany\u201d), a company specializing in the development of targeted, non-systemic\u00a0therapies for\u00a0gastrointestinal (GI) diseases, today announced that the Company will be participating in this year\u2019s Biotech Showcase Digital 2021 conference. James Sapirstein, President & CEO of AzurRx BioPharma, and the Company\u2019s senior management team will be participating in virtual one-on-one meetings with registered investors and pharmaceutical companies. The AzurRx team will be available to provide an overview of the Company\u2019s business and clinical development programs and discuss anticipated 2021 milestones. Details of the event are as follows: Event: \u00a0 Biotech Showcase Digital Date:\u00a0 \u00a0 January 11-15, 2021 Registration: \u00a0 https:\/\/informaconnect.com\/biotech-showcase\/registration-options\/ About AzurRx BioPharma, Inc. … Continue reading \"AzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-07T13:03:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTg5OSMzOTA4MTc5IzIwODIyMDc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference","datePublished":"2021-01-07T13:03:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/"},"wordCount":569,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTg5OSMzOTA4MTc5IzIwODIyMDc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/","name":"AzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTg5OSMzOTA4MTc5IzIwODIyMDc=","datePublished":"2021-01-07T13:03:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTg5OSMzOTA4MTc5IzIwODIyMDc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTg5OSMzOTA4MTc5IzIwODIyMDc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/azurrx-biopharma-to-participate-in-biotech-showcase-digital-2021-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/410244","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=410244"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/410244\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=410244"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=410244"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=410244"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}